From Our Perspective - 340B Matters
15581
page-template,page-template-blog-large-image,page-template-blog-large-image-php,page,page-id-15581,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-9.1.3,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

From Our Perspective

21 Sep 365 Days of No Penalties for Scofflaw Drug Companies

By 340B Matters It’s 365 days and counting since the Department of Health and Human Services referred scofflaw drug companies to the Office of Inspector General for assessment of civil monetary penalties for violating the 340B Drug Discount Program. It’s an anniversary that none of America’s...

Read More

16 Aug Celebrating 30 Years of 340B

By 340B Matters The 340B Drug Discount Program celebrates its 30th birthday this year. Over the past three decades, it has helped safety-net hospitals and clinics across the country care for underserved populations – just as Congress intended. These nonprofit healthcare organizations are on the front line....

Read More

26 Jul Feel the Love for 340B

By 340B Matters Big Pharma has been trying to maim or kill the 340B Drug Discount Program for years and hasn’t succeeded. That’s because it has enjoyed enormous bi-partisan support from successive presidential administrations as well as hundreds of members of the U.S. House and Senate. “Every...

Read More

01 Jul Where Are the Rest of America’s Attorneys General?

By 340B Matters Recently, 25 state attorneys general signed onto two friend-of-the-court briefs excoriating the drug industry for illegally denying discounts to hospitals and clinics in the federal 340B Drug Discount Program. We applaud these leaders – and particularly Connecticut Attorney General William Tong, for leading...

Read More

09 May Where Is the HHS Inspector General?

By 340B Matters So far, seven of the world’s largest drug manufacturers have been referred to the Department of Health and Human Services Office of Inspector General for blatantly breaking the law regarding the 340B Drug Discount Program. The situation has cost affected hospitals and clinics $6...

Read More

04 Mar Big Pharma Robs $6B from America’s Healthcare First Responders

By 340B Matters Big Pharma has stolen $6 billion from safety-net hospitals and clinics during the past two years. The effect has been huge, leading to service cutbacks to low-income patients amid a roiling pandemic. Fourteen gigantic drug companies have shamelessly robbed the 340B Drug Discount Program....

Read More

01 Dec Courts Say Big Pharma is Breaking the Law

By 340B Matters Despite Big Pharma’s efforts to eviscerate the 340B Drug Discount Program, recent federal court decisions have made it clear that manufacturers are acting illegally. Eli Lilly, along with eight other huge drug makers, have unilaterally limited required drug discounts to safety-net health care...

Read More

15 Nov Greed Pays Off for Eli Lilly

By 340B Matters The drug industry already has some of the highest profit margins of any sector and they're getting higher for Eli Lilly. U.S. revenues increased by a whopping 26% last quarter - that’s a big jump for a company that posted $6 billion in...

Read More

Want To Stay Up-To-Date On The Latest 340B News?